Sadguru Healthcare

The MAGLUMI T3 kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative determination of Triiodothyronine (T3) in human serum. T3 is a thyroid hormone that plays a crucial role in regulating metabolism, heart rate, and body temperature.

The MAGLUMI Thyroglobulin (Tg) kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative determination of thyroglobulin levels in human serum. This assay is intended for use with the MAGLUMI series of fully automated CLIA analyzers, including models such as MAGLUMI 1000, MAGLUMI 2000, MAGLUMI 2000 Plus, and newer models.  

The MAGLUMI Ferritin kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative determination of ferritin levels in human serum and plasma. Ferritin is a protein that stores iron in the body, and its measurement is essential for diagnosing and monitoring various conditions, including iron deficiency anemia and iron overload disorders.

The MAGLUMI 25-OH Vitamin D kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative determination of 25-hydroxyvitamin D (25-OH Vitamin D) levels in human serum and plasma. This assay is essential for assessing vitamin D sufficiency, which is crucial for bone health, immune function, and overall well-being.

The Maglumi Beta2-MG Kit is a chemiluminescence immunoassay (CLIA) reagent designed for the quantitative determination of β2-microglobulin (β2-MG) levels in human serum or urine samples. It is compatible with Snibe's Maglumi series of fully automated analyzers, such as the Maglumi 800 and Maglumi 2000. 

The MAGLUMI IgM kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the qualitative detection of immunoglobulin M (IgM) antibodies in human serum. IgM is the first antibody produced by the immune system in response to an infection, making its detection crucial for early diagnosis.

The MAGLUMI IgG kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative determination of immunoglobulin G (IgG) levels in human serum and plasma. IgG is the most abundant antibody in the blood and plays a crucial role in the body's defense against bacterial and viral infections.

The MAGLUMI IgA kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative determination of immunoglobulin A (IgA) levels in human serum and plasma. IgA is a crucial antibody involved in mucosal immunity, playing a significant role in protecting against infections.

The MAGLUMI Albumin kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative determination of albumin levels in human urine. Albumin is the most abundant extracellular protein, playing a crucial role in maintaining osmotic pressure and transporting various substances in the blood. Elevated levels of albumin in urine, known as albuminuria, can be indicative of kidney disease or other health conditions.

The Maglumi Insulin Kit is a chemiluminescence immunoassay (CLIA) reagent designed for the quantitative determination of insulin levels in human serum samples. It is compatible with Snibe's Maglumi series of fully automated analyzers, such as the Maglumi 800 and Maglumi 4000 Plus.

The MAGLUMI Cortisol kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative determination of cortisol levels in human serum. Cortisol is a steroid hormone produced by the adrenal glands, playing a crucial role in metabolism, immune response, and stress adaptation.

The MAGLUMI Free Estriol (f-E3) kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative determination of free estriol levels in human serum. Free estriol is a steroid hormone produced during pregnancy, and its measurement is commonly used in prenatal screening to assess fetal health and development.

The MAGLUMI D-Dimer kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative determination of D-Dimer levels in human serum and plasma. D-Dimer is a fibrin degradation product present in the blood after a blood clot dissolves, and elevated levels can indicate the presence of an abnormal blood clotting condition.

The MAGLUMI BNP kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative determination of B-type natriuretic peptide (BNP) in human EDTA plasma. BNP is a biomarker commonly used to assess heart failure and other cardiovascular conditions.

The MAGLUMI NT-proBNP kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative determination of N-terminal prohormone B-type natriuretic peptide (NT-proBNP) in human serum. NT-proBNP is a biomarker commonly used to assess heart failure and other cardiovascular conditions.

The MAGLUMI hs-CRP kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative determination of high-sensitivity C-reactive protein (hs-CRP) levels in human serum. Hs-CRP is a sensitive marker of systemic inflammation and is commonly used to assess the risk of cardiovascular diseases.

The MAGLUMI TSH (Thyroid-Stimulating Hormone) kit is an in vitro chemiluminescence immunoassay designed for the quantitative determination of TSH levels in human serum. This assay is intended for use with the MAGLUMI series of fully automated chemiluminescence immunoassay analyzers, including models such as MAGLUMI 1000, MAGLUMI 2000, MAGLUMI 2000 Plus, MAGLUMI 4000, MAGLUMI 4000 Plus, and MAGLUMI X8.  

The MAGLUMI Vitamin B12 kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative determination of vitamin B12 levels in human serum. Vitamin B12 is essential for red blood cell formation, neurological function, and DNA synthesis.

The MAGLUMI IgE kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative determination of immunoglobulin E (IgE) levels in human serum and plasma. IgE is an antibody associated with allergic reactions, and measuring its concentration can assist in diagnosing and monitoring allergic conditions.

The MAGLUMI Erythropoietin (EPO) kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative determination of erythropoietin levels in human serum and plasma. Erythropoietin is a hormone primarily produced by the kidneys that stimulates red blood cell production in the bone marrow. Measuring EPO levels is essential for diagnosing and monitoring various anemias and polycythemias.

The MAGLUMI MPO kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative determination of Myeloperoxidase (MPO) levels in human plasma. MPO is an enzyme produced by white blood cells and is considered a sensitive marker for cardiovascular inflammation.

The MAGLUMI AFP (Prenatal Screening) kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative determination of alpha-fetoprotein (AFP) levels in human serum. AFP is a glycoprotein produced by the fetal liver and yolk sac, and its measurement is commonly used in prenatal screening to assess the risk of fetal abnormalities.

The MAGLUMI Troponin I kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative detection of cardiac troponin I (cTnI) in human serum or plasma. cTnI is a highly specific biomarker for myocardial injury, making its measurement essential for diagnosing acute myocardial infarction (AMI) and assessing cardiac damage.

The Maglumi Myoglobin Kit is a diagnostic reagent designed for the quantitative determination of myoglobin levels in human serum and plasma. It is used with Snibe's Maglumi series of fully automated chemiluminescence immunoassay (CLIA) analyzers, such as the Maglumi M and X series.

The MAGLUMI hs-cTnI kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative determination of high-sensitivity cardiac troponin I (hs-cTnI) in human serum and plasma. Elevated levels of hs-cTnI are indicative of myocardial injury and are commonly used to diagnose acute myocardial infarction (heart attack).

The MAGLUMI CK-MB kit is an in vitro chemiluminescence immunoassay (CLIA) designed for the quantitative detection of creatine kinase-MB (CK-MB) isoenzyme in human serum or plasma. CK-MB is a cardiac-specific enzyme released into the bloodstream during myocardial injury, making its measurement crucial for diagnosing acute myocardial infarction (AMI) and assessing cardiac damage.

Snibe Maglumi Wash Concentrate is a reagent used in conjunction with the Maglumi series of immunoassay analyzers for washing samples during the testing process. Here’s an overview of its features and uses:

Key Features:

• Purpose: The wash concentrate is designed to clean the assay wells after the reaction phase, ensuring that non-specific binding and excess reagents are effectively removed, which enhances assay accuracy.
• Concentration: Typically provided as a concentrated solution that needs to be diluted with distilled or deionized water before use.
• Compatibility: Specifically formulated for use with Snibe Maglumi analyzers, ensuring optimal performance and reliable results.

The Snibe Maglumi Starter 1 Plus 2 Diagnostic Test Kit is designed for use with Snibe's Maglumi immunoassay analyzers. This kit facilitates the quantitative detection of various biomarkers, including hormones, proteins, and infectious disease markers, utilizing chemiluminescent technology.

Key Features:

• Multi-Parameter Testing: Supports the detection of multiple analytes, making it versatile for various diagnostic applications.
• High Sensitivity and Specificity: Utilizes advanced chemiluminescent immunoassay technology, ensuring accurate and reliable results.
• Rapid Results: Typically provides results quickly, enabling timely clinical decision-making.
• User-Friendly Interface: Designed for seamless integration with Snibe Maglumi analyzers, enhancing workflow efficiency in laboratories.

The Maglumi C-Peptide Kit is a chemiluminescence immunoassay (CLIA) reagent used for the quantitative measurement of C-peptide in human serum or plasma. It is run on the Maglumi CLIA system and is primarily used in assessing pancreatic β-cell function and insulin production.

Light control solution. For Snibe instruments from the Maglumi line: 800,2000,4000 and 2000plus. The package is 5x2mL. The product is original Snibe.

The Maglumi IL-6 Immunoassay Reagent is used in the Maglumi Chemiluminescence Immunoassay (CLIA) System for the quantitative measurement of interleukin-6 (IL-6) in human serum or plasma. IL-6 is a pro-inflammatory cytokine that plays a crucial role in immune responses, inflammation, and various diseases.

The Maglumi CA 19-9 test is an automated chemiluminescence immunoassay (CLIA) used to measure carbohydrate antigen 19-9 (CA 19-9) levels in human serum or plasma. This tumor marker is primarily associated with pancreatic cancer but can also be elevated in other gastrointestinal malignancies and benign conditions.

The Maglumi Reaction Module is a key component of the Maglumi Chemiluminescence Immunoassay (CLIA) System, responsible for conducting the reaction and detection processes during testing.

The Maglumi Anti-CCP test is an automated immunoassay used to detect anti-cyclic citrullinated peptide (anti-CCP) antibodies in human serum or plasma. It is performed using the Maglumi chemiluminescence immunoassay (CLIA) system, which is widely used in clinical laboratories for autoimmune disease diagnosis.

The Maglumi HSV-2 IgG test is a chemiluminescence immunoassay (CLIA) used for the quantitative detection of IgG antibodies against Herpes Simplex Virus Type 2 (HSV-2) in human serum or plasma. It is performed on the Maglumi CLIA system and is primarily used to assess past or ongoing HSV-2 infections.

The Maglumi HSV-1/2 IgG and IgM tests are chemiluminescence immunoassays (CLIA) used for the quantitative detection of IgG and IgM antibodies against Herpes Simplex Virus Type 1 (HSV-1) and Type 2 (HSV-2) in human serum or plasma. These tests are performed on the Maglumi CLIA system and help in diagnosing herpes simplex virus infections.

Troponin I (Tn-I) Plus can diagnose myocardial infarction and myocardial necrosis at an early stage with high sensitivity by accessing Tn-I level in the blood, thus can help prevent progression to more severe cases.

The Maglumi Reaction Cup is a consumable used in the Maglumi Chemiluminescence Immunoassay (CLIA) System. It serves as a disposable reaction vessel where the immunoassay reaction takes place during testing.

The Maglumi ANA Screen is an automated chemiluminescence immunoassay (CLIA) used for detecting antinuclear antibodies (ANA) in human serum or plasma. It is performed on the Maglumi immunoassay system and is primarily used in diagnosing autoimmune diseases.